A detailed history of Northwest Financial Advisors transactions in Royalty Pharma PLC stock. As of the latest transaction made, Northwest Financial Advisors holds 120 shares of RPRX stock, worth $3,027. This represents 0.0% of its overall portfolio holdings.

Number of Shares
120
Previous 126 4.76%
Holding current value
$3,027
Previous $3.32 Million 2.2%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$25.63 - $29.27 $153 - $175
-6 Reduced 4.76%
120 $3.4 Million
Q2 2024

Aug 12, 2024

BUY
$26.26 - $29.9 $157 - $179
6 Added 5.0%
126 $3.32 Million
Q4 2023

Feb 07, 2024

BUY
$26.21 - $29.22 $3,145 - $3,506
120 New
120 $3.37 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Northwest Financial Advisors Portfolio

Follow Northwest Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Financial Advisors with notifications on news.